U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232433) titled 'Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules' on Sept. 27.
Brief Summary: Lung cancer is the leading cause of cancer-related mortality worldwide, making early diagnosis and intervention critical. With the widespread adoption of low-dose computed tomography (LDCT) screening, the detection rate of pulmonary ground-glass nodules (GGNs) has increased significantly. Although video-assisted thoracoscopic surgery (VATS) remains the standard treatment for early-stage lung cancer, a considerable proportion of patients are ineligible for surgery due to advanced age, impaired cardiopulmonary function,...